المؤلفون: Jugler C; The Biodesign Institute, Arizona State University, Tempe, Arizona, USA.; School of Life Sciences, Arizona State University, Tempe, Arizona, USA., Sun H; The Biodesign Institute, Arizona State University, Tempe, Arizona, USA., Nguyen K; School of Molecular Sciences, Arizona State University, Tempe, Arizona, USA., Palt R; Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria., Felder M; Halberd Corporation, Jackson Center, Pennsylvania, USA., Steinkellner H; Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria., Chen Q; The Biodesign Institute, Arizona State University, Tempe, Arizona, USA.; School of Life Sciences, Arizona State University, Tempe, Arizona, USA.

المصدر: Plant biotechnology journal [Plant Biotechnol J] 2023 Mar; Vol. 21 (3), pp. 549-559. Date of Electronic Publication: 2022 Dec 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Wiley on behalf of the Society for Experimental Biology, Association of Applied Biologists Country of Publication: England NLM ID: 101201889 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1467-7652 (Electronic) Linking ISSN: 14677644 NLM ISO Abbreviation: Plant Biotechnol J Subsets: MEDLINE

مواضيع طبية MeSH: Combined Antibody Therapeutics* , COVID-19*, Humans ; Animals ; Mice ; SARS-CoV-2 ; Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antibodies, Viral

SCR Organism: SARS-CoV-2 variants

المؤلفون: Chi H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Zhao SQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Chen RY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Suo XX; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China.; College of Life Sciences, Inner Mongolia Agricultural University, Hohhot, 010018, Inner Mongolia, China., Zhang RR; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Yang WH; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Zhou DS; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China., Fang M; School of Life Sciences, Henan University, Kaifeng, 475004, Henan, China., Ying B; Suzhou Abogen Biosciences Co., Ltd, Suzhou, 215123, Jiangsu, China., Deng YQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China. dengyq1977@126.com., Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, 100071, Beijing, China. qincf@bmi.ac.cn.; Research Unit of Discovery and Tracing of Natural Focus Diseases, Chinese Academy of Medical Sciences, 100071, Beijing, China. qincf@bmi.ac.cn.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Mar 27; Vol. 9 (1), pp. 69. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

مواضيع طبية MeSH: Orthopoxvirus* , Vaccinia*/prevention & control, Animals ; Mice ; Combined Antibody Therapeutics ; Antibodies, Viral ; Vaccinia virus/genetics

المؤلفون: Sun C; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Chi H; Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, 100071, China., Yuan F; State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China., Li J; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Yang J; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Zheng A; State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China., Wang F; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Sun L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Zhang Y; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Hu P; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Jiao L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China., Deng Y; Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, 100071, China. dengyq1977@126.com., Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China. LX@sinocelltech.com.; Beijing Key Laboratory of Monoclonal Antibody Research and Development, Sino Biological Inc., Beijing, 100176, China. LX@sinocelltech.com.; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China. LX@sinocelltech.com.

المصدر: Science China. Life sciences [Sci China Life Sci] 2023 Jan; Vol. 66 (1), pp. 165-179. Date of Electronic Publication: 2022 Sep 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Science China Press, co-published with Springer Country of Publication: China NLM ID: 101529880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1869-1889 (Electronic) Linking ISSN: 16747305 NLM ISO Abbreviation: Sci China Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Combined Antibody Therapeutics* , COVID-19*/prevention & control, Animals ; Mice ; Antibodies, Neutralizing ; Antibodies, Viral ; Epitopes/genetics ; Mutation ; SARS-CoV-2

SCR Organism: SARS-CoV-2 variants

المؤلفون: Hong J; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Zhong L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Liu L; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Wu Q; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Zhang W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Chen K; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Wei D; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Sun H; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Zhou X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Kang YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Huang Y; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Chen J; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Wang G; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Zhou Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Chen Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Feng QS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Yu H; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Li S; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China., Zeng MS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zeng YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Xu M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Electronic address: xumiao@sysucc.org.cn., Zheng Q; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China. Electronic address: abing0811@xmu.edu.cn., Chen Y; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China. Electronic address: yxchen2008@xmu.edu.cn., Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; College of Pharmacy, Chongqing Medical University, Chongqing 400016, China. Electronic address: 103193@cqmu.edu.cn., Xia N; State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, Research Unit of Frontier Technology of Structural Vaccinology of the Chinese Academy of Medical Sciences, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361005, China. Electronic address: nsxia@xmu.edu.cn.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Nov 21; Vol. 4 (11), pp. 101296.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections* , Vaccines*, Animals ; Mice ; Viral Envelope Proteins/chemistry ; Membrane Glycoproteins ; Herpesvirus 4, Human ; Viral Proteins ; Combined Antibody Therapeutics ; Epitopes ; Glycoproteins ; Antibodies, Neutralizing/therapeutic use

المؤلفون: Liu G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Chan M; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Zhang Z; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada., Schulz H; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Cao W; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Rahim MN; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Garnett L; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada., Wec A; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York., Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Banadyga L; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

المصدر: The Journal of infectious diseases [J Infect Dis] 2023 Nov 13; Vol. 228 (Suppl 7), pp. S691-S700.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Hemorrhagic Fever, Ebola* , Ebolavirus*, Humans ; Animals ; Guinea Pigs ; Mice ; Antibodies, Monoclonal ; Combined Antibody Therapeutics ; Antibodies, Neutralizing ; Antibodies, Viral

المؤلفون: Li X; Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Institute for Brain Science and Disease, Chongqing Medical University, Chongqing, 400016, China., Peng P; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, Chongqing Medical University, Chongqing, China.; Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China., Deng H; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, Chongqing Medical University, Chongqing, China.; Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China., Yang Q; Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Chen S; Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Li B; Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., He M; Laboratory Animal Center of Chongqing Medical University, Chongqing, China., Jin A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China., Yang Z; Department of Gynecology and Obstetrics, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China., Tang N; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, Chongqing Medical University, Chongqing, China. nitang@cqmu.edu.cn.; Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. nitang@cqmu.edu.cn., Huang A; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.; Institute for Viral Hepatitis, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. ahuang@cqmu.edu.cn.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Oct 23; Vol. 8 (1), pp. 403. Date of Electronic Publication: 2023 Oct 23.

نوع المنشور: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*, Humans ; Combined Antibody Therapeutics ; SARS-CoV-2 ; Post-Exposure Prophylaxis ; Antibodies, Neutralizing

المؤلفون: Takashima Y; Dept. of Breast Surgery, Hirakata City Hospital., Terasawa R, Hirata A, Morita S, Kimura K, Iwamoto M, Hayashi M

المصدر: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2023 Sep; Vol. 50 (9), pp. 1009-1011.

نوع المنشور: Case Reports; English Abstract; Journal Article

بيانات الدورية: Publisher: Gan To Kagaku Ryohosha Country of Publication: Japan NLM ID: 7810034 Publication Model: Print Cited Medium: Print ISSN: 0385-0684 (Print) Linking ISSN: 03850684 NLM ISO Abbreviation: Gan To Kagaku Ryoho Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/surgery , Breast Neoplasms*/pathology , COVID-19*, Female ; Humans ; Middle Aged ; Capecitabine/therapeutic use ; Combined Antibody Therapeutics ; COVID-19 Drug Treatment ; Mastectomy

المؤلفون: Ma H; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China.; School of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China., Zong HF; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China.; Jecho Institute, Co., Ltd., Shanghai, 200240, China., Liu JJ; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Yue YL; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Ke Y; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Liao YJ; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Tang HN; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Wang L; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Wang SS; Jecho Laboratories, Inc., Frederick, MD, 21704, USA., Yuan YS; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Wu MY; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Bian YL; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Zhang BH; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Yin HY; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China., Jiang H; Jecho Laboratories, Inc., Frederick, MD, 21704, USA., Sun T; School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 200240, China.; Shanghai Municipal Veterinary Key Laboratory, Shanghai, 200240, China., Han L; Jecho Institute, Co., Ltd., Shanghai, 200240, China. lei.han@jechobio.com., Xie YQ; Jecho Laboratories, Inc., Frederick, MD, 21704, USA. yueqing.xie@jecholabs.com., Zhu JW; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, Shanghai, 200240, China. jianweiz@sjtu.edu.cn.; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China. jianweiz@sjtu.edu.cn.

المصدر: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2023 Jul; Vol. 44 (7), pp. 1455-1463. Date of Electronic Publication: 2023 Jan 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Antibodies, Bispecific*/therapeutic use, Humans ; SARS-CoV-2 ; Combined Antibody Therapeutics ; Neutralization Tests ; Antibodies, Neutralizing

المؤلفون: Addetia A; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA; Department of Biochemistry, University of Washington, Seattle, WA, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Starr T; Howard Hughes Medical Institute, Seattle, WA 98195, USA; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Greaney AJ; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA., Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA, USA., Tiles SW; Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA., Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA., Bloom JD; Howard Hughes Medical Institute, Seattle, WA 98195, USA; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu.

المصدر: Cell reports [Cell Rep] 2023 Jun 27; Vol. 42 (6), pp. 112621. Date of Electronic Publication: 2023 May 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2* , COVID-19*, Humans ; Combined Antibody Therapeutics ; Antibodies, Viral ; Antibodies, Neutralizing ; Antibodies, Monoclonal ; Spike Glycoprotein, Coronavirus ; Neutralization Tests

SCR Organism: SARS-CoV-2 variants

المؤلفون: Subhash Walinjkar R; Sevenhills Healthcare Pvt. Ltd., Mumbai, Maharashtra, India., Kumbhar M; Sevenhills Healthcare Pvt. Ltd., Mumbai, Maharashtra, India., Harihar Shinde R; Sevenhills Healthcare Pvt. Ltd., Mumbai, Maharashtra, India., Chaurasia E; Sevenhills Healthcare Pvt. Ltd., Mumbai, Maharashtra, India.

المصدر: Journal of infection in developing countries [J Infect Dev Ctries] 2023 Mar 31; Vol. 17 (3), pp. 293-301. Date of Electronic Publication: 2023 Mar 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet ISSN: 1972-2680 (Electronic) Linking ISSN: 19722680 NLM ISO Abbreviation: J Infect Dev Ctries Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*, Humans ; Middle Aged ; Retrospective Studies ; SARS-CoV-2 ; Combined Antibody Therapeutics

SCR Organism: SARS-CoV-2 variants